NCT07231757Recruiting

The RADIANCE CED Study

ReCor Medical, Inc.

Start Date

11/21/2025

Completion Date

12/31/2031

Summary

The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.

Eligibility Criteria

Age Range: 65 years to No maximum

Common Inclusion Criteria: * Adults aged ≥65 years with uncontrolled hypertension * Stable regimen of blood pressure-lowering medication Common Exclusion Criteria: * Hypertension due to secondary causes * Prior renal denervation treatment * Pregnancy * End-stage renal disease, dialysis, or kidney transplant

Interventions

DEVICE

Ultrasound Renal Denervation (Paradise™ Ultrasound Renal Denervation (uRDN) System)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

HypertensionCardiovascular DiseasesVascular Diseases

Locations

Henry Ford Hospital

Detroit, Michigan 48202

United States

Henry Ford St. John Hospital

Detroit, Michigan 48236

United States